Results 211 to 220 of about 45,277 (241)
Lidocaine and remifentanil for ventricular tachycardia suppression in a dog: A case report. [PDF]
Open Vet JPahim ABS +8 more
europepmc +1 more source
Comparison of Two Initial Effect-Site Concentrations of Remifentanil with Propofol During Percutaneous Vertebroplasty Under Monitored Anesthesia Care: A Randomized Controlled Study with Titration-Based Adjustment. [PDF]
J Clin MedLin SS +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Critical Care, 2001
Remifentanil is an opioid with a unique pharmacokinetic profile. Its metabolism by nonspecific esterases results in rapid and uniform clearance leading to highly predictable onset and offset of action. This review will describe the features that set remifentanil apart from other opioids and outline its potential usefulness in a critical care setting ...
J, Cohen, D, Royston
openaire +2 more sources
Remifentanil is an opioid with a unique pharmacokinetic profile. Its metabolism by nonspecific esterases results in rapid and uniform clearance leading to highly predictable onset and offset of action. This review will describe the features that set remifentanil apart from other opioids and outline its potential usefulness in a critical care setting ...
J, Cohen, D, Royston
openaire +2 more sources
Drugs, 1996
Remifentanil is a new selective mu opioid receptor agonist of higher potency than alfentanil, with pharmacological effects that essentially parallel those of alfentanil and other opioids in this class. Unlike other opioids, remifentanil is rapidly hydrolysed by nonspecific plasma and tissue esterases: this imparts brevity of action, precise and rapidly
S S, Patel, C M, Spencer
openaire +2 more sources
Remifentanil is a new selective mu opioid receptor agonist of higher potency than alfentanil, with pharmacological effects that essentially parallel those of alfentanil and other opioids in this class. Unlike other opioids, remifentanil is rapidly hydrolysed by nonspecific plasma and tissue esterases: this imparts brevity of action, precise and rapidly
S S, Patel, C M, Spencer
openaire +2 more sources
The pharmacokinetics of remifentanil
Journal of Clinical Anesthesia, 1996Opioids decrease the sympathetic and somatic responses to noxious stimulation and can be given in high doses without negative inotropic effects, even in patients with impaired cardiac function. With currently available opioids, precise titration of dose to effect is difficult, and high doses result in drug accumulation and prolonged respiratory ...
L G, Michelsen, C C, Hug
openaire +2 more sources
Acta Anaesthesiologica Scandinavica, 2008
Background and aim: Remifentanil is an ultra‐short‐acting opioid, increasingly used today in neuroanesthesia and neurointensive care. Its characteristics make remifentanil a potentially ideal agent, but previous data have cast a shadow on this opioid, supporting potentially toxic effects on the ischemic brain.
FODALE, Vincenzo +3 more
openaire +3 more sources
Background and aim: Remifentanil is an ultra‐short‐acting opioid, increasingly used today in neuroanesthesia and neurointensive care. Its characteristics make remifentanil a potentially ideal agent, but previous data have cast a shadow on this opioid, supporting potentially toxic effects on the ischemic brain.
FODALE, Vincenzo +3 more
openaire +3 more sources
Antibacterial activity of remifentanil and mixtures of remifentanil and propofol
Journal of Clinical Anesthesia, 2007To investigate the antibacterial activity of glycine, which is contained in remifentanil, when combined with propofol.Prospective study.Departments of anesthesiology and microbiology of a university hospital.Growth of the microorganisms Staphylococcus epidermidis, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Candida albicans in ...
Apan, Teornan Zafer +3 more
openaire +3 more sources
Pediatric Anesthesia, 2010
SummaryRemifentanil has gained the confidence of anesthesiologists and has given a real opportunity to change the way anesthesia is given. It can be considered the ideal opioid despite many obstacles to pediatric use: the condition of ‘off‐label’, the lack of wide randomized clinical trials, and the fear of adverse events because of its high potency ...
Maria, Sammartino +4 more
openaire +2 more sources
SummaryRemifentanil has gained the confidence of anesthesiologists and has given a real opportunity to change the way anesthesia is given. It can be considered the ideal opioid despite many obstacles to pediatric use: the condition of ‘off‐label’, the lack of wide randomized clinical trials, and the fear of adverse events because of its high potency ...
Maria, Sammartino +4 more
openaire +2 more sources